Trial Profile
Optimising Protection for Pregnant Women and Infants With Maternal Vaccination
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Feb 2024
Price :
$35
*
At a glance
- Drugs DTaP vaccine (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza virus infections; Pertussis
- Focus Pharmacodynamics
- Acronyms OPTIWIN
- 29 Jan 2024 Planned End Date changed from 30 May 2021 to 1 Mar 2024.
- 29 Jan 2024 Status changed from recruiting to active, no longer recruiting.
- 18 Jul 2018 Status changed from not yet recruiting to recruiting.